Catalyst Pharmaceuticals Inc Earnings

Catalyst Pharmaceuticals Inc’s revenue jumped 43.56% since last year same period to $141.42Mn in the Q1 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated -0.28% fall in its revenue since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit jumped 143.77% since last year same period to $56.74Mn in the Q1 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 1.43% jump in its net profits since last 3-months.

Catalyst Pharmaceuticals Inc’s net profit margin jumped 69.8% since last year same period to 40.12% in the Q1 2025. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 1.72% jump in its net profit margins since last 3-months.

Catalyst Pharmaceuticals Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 13.19.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.37 - a -7.16% fall from last quarter’s estimates.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.37.

Catalyst Pharmaceuticals Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Catalyst Pharmaceuticals Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.